116 related articles for article (PubMed ID: 2725744)
21. Combined use of inactivated and oral poliovirus vaccines in a large-scale campaign in refugee camps and host communities – Kenya, December 2013.
Wkly Epidemiol Rec; 2014 Mar; 89(12):127-32. PubMed ID: 24707518
[No Abstract] [Full Text] [Related]
22. The most ambitious vaccine introduction in history.
Miller E
Vaccine; 2014 Aug; 32(36):4599-601. PubMed ID: 24984120
[No Abstract] [Full Text] [Related]
23. Poliomyelitis.
Bennett ML
Nurs Mirror Midwives J; 1976 Nov; 143(22):64-5. PubMed ID: 1050005
[No Abstract] [Full Text] [Related]
24. The problems of poliovirus immunization.
Fulginiti VA
Hosp Pract; 1980 Aug; 15(8):61-7. PubMed ID: 6249713
[No Abstract] [Full Text] [Related]
25. Poliovaccine.
Lancet; 1983 May; 1(8332):1022-23. PubMed ID: 6133064
[No Abstract] [Full Text] [Related]
26. On reducing the risk of vaccine-associated paralytic poliomyelitis in the global transition from oral to inactivated poliovirus vaccine.
Peng X; Hu X; Salazar MA
Lancet; 2018 Aug; 392(10147):610-612. PubMed ID: 29605427
[No Abstract] [Full Text] [Related]
27. The natural history of poliomyelitis in Israel, 1949-1982.
Goldblum N; Swartz T; Gerichter CB; Handsher R; Lasch EE; Melnick JL
Prog Med Virol; 1984; 29():115-23. PubMed ID: 6366916
[No Abstract] [Full Text] [Related]
28. Poliovirus vaccines: live or dead.
Ogra PL; Faden HS
J Pediatr; 1986 Jun; 108(6):1031-3. PubMed ID: 3712146
[No Abstract] [Full Text] [Related]
29. Risk management in a polio-free world.
Bruce Aylward R; Sutter RW; Cochi SL; Thompson KM; Jafari H; Heymann D
Risk Anal; 2006 Dec; 26(6):1441-8. PubMed ID: 17184391
[TBL] [Abstract][Full Text] [Related]
30. Medicine and the media: polio still paralyses (Albert Sabin, Jonas Salk).
Dixon B
Br J Hosp Med; 1977 Dec; 18(6):595. PubMed ID: 342023
[No Abstract] [Full Text] [Related]
31. Criteria for control of infectious diseases with poliomyelitis as an example.
Evans AS
Prog Med Virol; 1984; 29():141-65. PubMed ID: 6322231
[No Abstract] [Full Text] [Related]
32. [Control of poliomyelitis. I. Retrospective view and current situation in the world with special reference to our country].
Vecchi C
Ann Sclavo; 1972; 14(6):665-93. PubMed ID: 4360237
[No Abstract] [Full Text] [Related]
33. Paralytic poliomyelitis--United States, 1980-1994.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Jan; 46(4):79-83. PubMed ID: 9048844
[TBL] [Abstract][Full Text] [Related]
34. Polio.
McFee RB
Dis Mon; 2013 Dec; 59(12):445-7. PubMed ID: 24314810
[No Abstract] [Full Text] [Related]
35. Vaccination against poliomyelitis in Canada.
Can J Public Health; 1967 Oct; 58(10):467-8. PubMed ID: 6079742
[No Abstract] [Full Text] [Related]
36. Polio vaccination: preparing for a change of routine.
Parker EP; Grassly NC
Lancet; 2016 Jul; 388(10040):107-8. PubMed ID: 27212428
[No Abstract] [Full Text] [Related]
37. When can we stop using oral poliovirus vaccine?
Hull HF; Minor PD
J Infect Dis; 2005 Dec; 192(12):2033-5. PubMed ID: 16288363
[No Abstract] [Full Text] [Related]
38. Epidemiology of poliomyelitis--options and update.
Dutta A
Vaccine; 2008 Oct; 26(45):5767-73. PubMed ID: 18755232
[TBL] [Abstract][Full Text] [Related]
39. Professor Natan Goldblum and the combined vaccination program in Gaza.
Tulchinsky T
Am J Public Health; 2011 May; 101(5):774-5; author reply 775. PubMed ID: 21490330
[No Abstract] [Full Text] [Related]
40. [Vaccination against poliomyelitis. Should attenuated oral vaccine replace inactive injectable vaccine?].
Maurin J
Presse Med (1893); 1966 Jul; 74(35):1797-9. PubMed ID: 5943741
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
